| Full title | Oral spray insulin in patients
with type 1 diabetes |
Summary
| This
study aims to evaluate whether treatment with oral spray insulin in patients with
type 1 diabetes can replace the subcutaneous route of insulin administration by
measuring blood glucose and insulin levels. |
| Time
frame | The study will run for six months. |
| Funded
by | Generex Inc., Canada |
| Project
leader for Campus Bio-Medico | This study will, for its entirety, be
run at the Center for Prevention of Diabetes at the Campus Bio-Medico |
| Main
partners | none |
| Campus
Bio-Medico role | major |
| Reference
web site | www.unicampus.it
www.generex.com |
| Notes | This
study should determine whether oral spray insulin can replace subcutaneous insulin
in patients with type 1 diabetes. This preliminary study, which will run on a
short and acute test, (breakfast test followed by measurement of blood glucose
under different experimental conditions) will tell us whether this insulin formulation
can be used for long term studies in patients with type 1 diabetes. |
